Estrella Immunopharma, Inc. · NASDAQ:ESLA
Estrella Immunopharma, Inc. shareholders
As of Jun 30, 2026, 14 institutions reported holding Estrella Immunopharma, Inc., 11.0% of its shares. Largest: Armistice Capital, LLC, Vanguard and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Estrella Immunopharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 3.98M | 9.1% | −124K | Aug 14, 2026 |
| Vanguard | 482K | 1.1% | +34,383 | Aug 13, 2026 |
| Geode Capital | 141K | 0.32% | −16,164 | Aug 12, 2026 |
| BlackRock | 52,033 | 0.12% | +12,143 | Aug 7, 2026 |
| State Street | 43,252 | 0.10% | no change | Aug 7, 2026 |
| Renaissance Technologies | 39,100 | 0.09% | −23,695 | Aug 13, 2026 |
| Northern Trust | 34,861 | 0.08% | +15,237 | Aug 13, 2026 |
| US Bancorp \de\ | 20,000 | 0.05% | +3,096 | Aug 12, 2026 |
| Tower Research Capital LLC (TRC) | 3,308 | <0.01% | −1,551 | Aug 11, 2026 |
| UBS | 1,721 | <0.01% | −13,358 | Aug 13, 2026 |